Article Sidebar

Submitted
May 16, 2024
Accepted
May 16, 2024
Published
May 16, 2024
Download
PDF
Statistic
Read Counter : 369 Download : 238

Main Article Content

Abstract

The rapid increase in the prevalence of cardiovascular diseases and low vitamin D levels are both
considered important public health issues. low level of vitamin D can promote endothelial dysfunction
and the development of atherosclerosis. also Vitamin D receptors are also expressed in the
cardiomyocytes of the left ventricle. One of the important mechanisms by which vitamin D affects
cardiovascular health is its effect on adipose tissue. Vitamin D can modulate the inflammatory response
of immune cells and adipocytes inside adipose tissue. Given the importance of vitamin D levels and
their relationship to adipose tissue in people with cardiovascular disease, understanding the mechanisms
of action of vitamin D in adipocytes may have a significant impact on maintaining cardiovascular health.
In the present review, we focus on mechanisms through which vitamin D may influence adipose tissue
associated with cardiovascular disease. In addition to checking whether vitamin D supplementation can
be a treatment option to improve adipose tissue function and thus prevent cardiovascular disease

Keywords

cardiovascular Vitamin D Adipose tissue

Article Details

License

Copyright (c) 2024 University of Thi-Qar Journal Of Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. -Sadeghi M, Haghdoost AA, Bahrampour A, Dehghani M. Modeling the burden of cardiovascular
  2. diseases in Iran from 2005 to 2025: the impact of demographic changes. Iran J Public Health.
  3. ;46(4):506
  4. -GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality
  5. for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global
  6. Burden of Disease Study 2017. Lancet 2018;392:1736–88.
  7. - Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030.
  8. PLoS Med. 2006;3(11):e442.
  9. -Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019)
  10. Results. Seattle, WA: Institute for Health Metrics and Evaluation (IHME); 2020.
  11. - Mohammad AA, Rashad HH, Habeeb QS, Rashad BH and Saeed SY. Demographic, clinical and
  12. angiographic profile of coronary artery disease in Kurdistan Region of Iraq. Am J Cardiovasc Dis. 2021;
  13. (1): 39-45.
  14. -Mendis S, Puska P, Norrving B, Organization WH. Global atlas on cardiovascular disease prevention
  15. and control. Geneva: World Health Organization; 2011.
  16. - Ofori EK, Intifu FD, Asante M, Asare GA, Adjei PK, Steele-Dadzie RK, et al. Prevalence of
  17. cardiovascular disease risk factors among students of a tertiary institution in Ghana. Food Sci Nutr.
  18. ; 6: 381-387.
  19. -Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, et al.
  20. Atherogenic index of plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran.
  21. ;29:240.
  22. - Ordovas JM. Genetic interactions with diet influence the risk of cardiovascular disease. Am J Clin
  23. Nutr. 2006;83(2):443S–6S.
  24. - Martirosyan DM, Miroshnichenko LA, Kulakova SN, Pogojeva AV, Zoloedov VI. Amaranth oil
  25. application for coronary heart disease and hypertension. Lipids Health Dis. 2007;6(1):1.
  26. - Després J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881.
  27. - Pengpid S and Peltzer K. Overweight and Obesity among Adults in Iraq: Prevalence and Correlates
  28. from a National Survey in 2015. Int. J. Environ. Res. Public Health 2021; 18, 4198.
  29. - Cortese, F., Costantino, M.F., Luzi, G. et al. Vitamin D and cardiovascular disease risk. A literature
  30. overview. Mol Biol Rep 49, 8925–8942 (2022).
  31. -Kheiri, B., Abdalla, A., Osman, M. et al. Vitamin D deficiency and risk of cardiovascular diseases: a
  32. narrative review. Clin Hypertens 24, 9 (2018).
  33. -Holick, M.F. Sunlight, UV Radiation, Vitamin D, and Skin Cancer: How Much Sunlight Do We
  34. Need? Adv. Exp. Med. Biol. 2020, 1268, 19–36.
  35. -Mawer, E.B.; Backhouse, J.; Holman, C.A.; Lumb, G.A.; Stanbury, S.W. The distribution and
  36. storage of vitamin D and its metabolites in human tissues. Clin. Sci. 1972, 43, 413–431.
  37. - Latic, N.; Erben, R.G. Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension,
  38. atherosclerosis, and Heart Failure. Int. J. Mol. Sci. 2020, 21, 6483.
  39. -Institute of Medicine. Dietary Reference Intakes: Calcium and Vitamin D; National Academies
  40. Press: Washington, DC, USA, 2011.
  41. - Pilz, S.; Zittermann, A.; Trummer, C.; Theiler-Schwetz, V.; Lerchbaum, E.; Keppel, M.H.; Grübler,
  42. M.R.; März, W.; Pandis, M. Vitamin D testing and treatment: A narrative review of current
  43. evidence. Endocr. Connect. 2019, 8, R27–R43.
  44. Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D,
  45. Mughal MZ, Mäkitie O, Ramos-Abad L, Ward L, DiMeglio LA, Atapattu N, Cassinelli H, Braegger C,
  46. Pettifor JM, Seth A, Idris HW, Bhatia V, Fu J, Goldberg G, Sävendahl L, Khadgawat R, Pludowski P,
  47. Maddock J, Hyppönen E, Oduwole A, Frew E, Aguiar M, Tulchinsky T, Butler G, Högler W. Global
  48. Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol
  49. Metab 2016;101:394-415. Epub 2016 Jan 8
  50. -EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific opinion on
  51. dietary reference values for vitamin D. EFSA J. 2016, 14, 4547.
  52. -DGE (German Nutrition Society), Österreichische Gesellschaft für Ernährung, Schweizerische
  53. Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung. D-A-CH
  54. Referenzwerte für die Nährstoffzufuhr, 1st ed.; 5. korrigierter Nachdruck 2013; Neuer Umschau
  55. Buchverlag: Neustadt an der Weinstraße, Germany, 2012.
  56. -Nordic Council of Ministers. Nordic Nutrition Recommendations 2012, 5th ed.; Narayana Press:
  57. Odder, Denmark, 2014.
  58. -Nair R, Maseeh A. Vitamin D: The sunshine vitamin. J PharmacolPharmacother. 2012;3(2):118–26.
  59. -Mohammed, Lina Y., et al. "The Prevalence of Vitamin D Deficiency and Associated Risk Factors
  60. among General Populations in Duhok Province, Kurdistan Region, Iraq." J Contemp Med Sci| Vol 7.6
  61. (2021): 330-333.
  62. - A. M. Issa and S. A. Ibraheem, “Alterations of Vitamin “D” level in Sera of Iraqi Population,”
  63. Journal of Kerbala University, vol. 5, no. 1, pp. 58-64, 2007].
  64. -Mahdi M, Hantoosh H, Imran B, Yahya A. Prevalence of vitamin D deficiency in Iraqi female at
  65. reproductive age. Medical Journal of Babylon.; 16(2) (2019
  66. -Al-Alyani H, Al-Turki HA, Al-Essa ON, Alani FM, Sadat-Ali M. Vitamin D deficiency in Saudi
  67. Arabians: A reality or simply hype: A meta-analysis (2008-2015). J Family Community Med.; 25(1):1-4
  68. (2018).
  69. - Hussein, Ibrahim Hani, et al. "Real-Life Data on Total Vitamin D3 (25-Hydroxyvitamin D)
  70. Concentrations in Basrah, Iraq." Biomedical & Pharmacology Journal 14.4 (2021): 2191-2198.
  71. -Hassan-Smith, Zaki K., Martin Hewison, and Neil J. Gittoes. "Effect of vitamin D deficiency in
  72. developed countries." British medical bulletin 122.1 (2017): 79-89.
  73. - Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al.
  74. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort
  75. and randomised intervention studies. BMJ. (2014) 348:g1903. doi: 10.1136/bmj.g1903
  76. - Gouni-Berthold, Ioanna, and Heiner K. Berthold. "Vitamin D and vascular disease." Current
  77. vascular pharmacology 19.3 (2021): 250-268.
  78. -Latic, N.; Erben, R.G. Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension,
  79. atherosclerosis, and Heart Failure. Int. J. Mol. Sci. 2020, 21, 6483.
  80. -Norman, P.E.; Powell, J.T. Vitamin D and cardiovascular disease. Circ. Res. 2014, 114, 379–393.
  81. -Condoleo, V.; Pelaia, C.; Armentaro, G.; Severini, G.; Clausi, E.; Cassano, V.; Miceli, S.; Fiorentino,
  82. T.V.; Succurro, E.; Arturi, F.; et al. Role of Vitamin D in Cardiovascular Diseases. Endocrines 2021, 2,
  83. -426.
  84. -Chen, S.; Glenn, D.J.; Ni, W.; Grigsby, C.L.; Olsen, K.; Nishimoto, M.; Law, C.S.; Gardner, D.G.
  85. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension 2008, 52,
  86. –1112.
  87. - Zittermann, A.; Schleithoff, S.S.; Tenderich, G.; Berthold, H.K.; Körfer, R.; Stehle, P. Low vitamin
  88. D status: A contributing factor in the pathogenesis of congestive heart failure? J. Am. Coll. Cardiol.
  89. , 41, 105–112.
  90. -Chanakul, A.; Zhang, M.Y.H.; Louw, A.; Armbrecht, H.J.; Miller, W.L.; Portale, A.A.; Perwad, F.
  91. FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues. PLoS ONE 2013, 8,
  92. e72816.
  93. -Somjen, D.; Weisman, Y.; Kohen, F.; Gayer, B.; Limor, R.; Sharon, O.; Jaccard, N.; Knoll, E.; Stern,
  94. N. 25-Hydroxyvitamin D3-1-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is
  95. Upregulated by Parathyroid Hormone and Estrogenic Compounds. Circulation 2005, 111, 1666–1671.
  96. -Scialla, J.J.; Wolf, M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.
  97. Nat. Rev. Nephrol. 2014, 10, 268–278.
  98. -Schmidt, N.; Brandsch, C.; Kühne, H.; Thiele, A.; Hirche, F.; Stangl, G.I. Vitamin D receptor
  99. deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in
  100. mice. PLoS ONE 2012, 7, e35316
  101. -Schmidt, N.; Brandsch, C.; Schutkowski, A.; Hirche, F.; Stangl, G.I. Dietary vitamin D inadequacy
  102. accelerates calcification and osteoblast-like cell formation in the vascular system of LDL receptor
  103. knockout and wild-type mice. J. Nutr. 2014, 144, 638–646.
  104. Mutt SJ, Hyppönen E, Saarnio J, Järvelin MR, Herzig KH. Vitamin D and adipose tissue-more than
  105. storage. Front Physiol 2014;5:228.
  106. - Nimitphong, Hataikarn, Eunmi Park, and Mi-Jeong Lee. "Vitamin D regulation of adipogenesis and
  107. adipose tissue functions." Nutrition research and practice 14.6 (2020): 553.
  108. -Park, C.Y.; Han, S.N. The role of vitamin D in adipose tissue biology: Adipocyte differentiation,
  109. energy metabolism, and inflammation. J. Lipid Atheroscler. 2021, 10, 130.
  110. -Yuzbashian, E.; Asghari, G.; Hedayati, M.; Zarkesh, M.; Mirmiran, P.; Khalaj, A. Determinants of
  111. vitamin D receptor gene expression in visceral and subcutaneous adipose tissue in non-obese, obese, and
  112. morbidly obese subjects. J. Steroid Biochem. Mol. Biol. 2019, 187, 82–87.
  113. -Rosenstreich, S.J.; Rich, C.; Volwiler, W. Deposition in and release of vitamin D 3 from body fat:
  114. Evidence for a storage site in the rat. J. Clin. Investig. 1971, 50, 679–687.
  115. Clemente-Postigo M, Muñoz-Garach A, Serrano M, Garrido-Sánchez L, Bernal-López MR,
  116. Fernández-García D, Moreno-Santos I, Garriga N, Castellano-Castillo D, Camargo A, Fernández-Real
  117. JM, Cardona F, Tinahones FJ, Macías-González M. Serum 25-hydroxyvitamin D and adipose tissue
  118. vitamin D receptor gene expression: relationship with obesity and type 2 diabetes. J Clin Endocrinol
  119. Metab 2015;100:E591-5.
  120. - Płudowski, P.; Kos-Kudła, B.; Walczak, M.; Fal, A.; Zozulińska-Ziółkiewicz, D.; Sieroszewski, P.;
  121. Peregud-Pogorzelski, J.; Lauterbach, R.; Targowski, T.; Lewiński, A. Guidelines for preventing and
  122. treating vitamin D deficiency: A 2023 update in Poland. Nutrients 2023, 15, 695.
  123. -Szymczak-Pajor, I.; Miazek, K.; Selmi, A.; Balcerczyk, A.; Śliwińska, A. The action of vitamin D in
  124. adipose tissue: Is there the link between vitamin D deficiency and adipose tissue-related metabolic
  125. disorders? Int. J. Mol. Sci. 2022, 23, 956.
  126. -Gangloff, A.; Bergeron, J.; Lemieux, I.; Després, J.-P. Changes in circulating vitamin D levels with
  127. loss of adipose tissue. Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 464–470.
  128. -Didriksen, A.; Burild, A.; Jakobsen, J.; Fuskevåg, O.M.; Jorde, R. Vitamin D3 increases in
  129. abdominal subcutaneous fat tissue after supplementation with vitamin D3. Eur. J. Endocrinol. 2015, 172,
  130. –241.
  131. -Martinaityte, I.; Kamycheva, E.; Didriksen, A.; Jakobsen, J.; Jorde, R. Vitamin D stored in fat tissue
  132. during a 5-year intervention affects serum 25-hydroxyvitamin D levels the following year. J. Clin.
  133. Endocrinol. Metab. 2017, 102, 3731–3738.
  134. -da Silva, E.M.S.; Pinho, H.S.; Rodrigues, I.G.; Pinho, C.P.S. Asociación entre los niveles séricos de
  135. vitamina D y las alteraciones cardiometabólicas. Nutr. Clínica Dietética Hosp. 2019, 39, 86–93.
  136. -da Silva, S.; Maria, E.; Pinho; Sabino, H.; Rodrigues; Galvão1, I.; Pinho; Sabino, C.P. Association
  137. between serum vitamin D levels and cardiometabolic alterations. Nutr. Clín. Diet. Hosp. 2019, 39, 86–
  138. -Carrelli, A.; Bucovsky, M.; Horst, R.; Cremers, S.; Zhang, C.; Bessler, M.; Schrope, B.; Evanko, J.;
  139. Blanco, J.; Silverberg, S.J. Vitamin D storage in adipose tissue of obese and normal weight women. J.
  140. Bone Miner. Res. 2017, 32, 237–242.
  141. -Wortsman, J.; Matsuoka, L.Y.; Chen, T.C.; Lu, Z.; Holick, M.F. Decreased bioavailability of vitamin
  142. D in obesity. Am. J. Clin. Nutr. 2000, 72, 690–693.
  143. -Hey, H.; Stokholm, K.; Lund, B.; Sørensen, O. Vitamin D deficiency in obese patients and changes
  144. in circulating vitamin D metabolites following jejunoileal bypass. Int. J. Obes. 1982, 6, 473–479.
  145. -de Souza, Wysllenny Nascimento, and Ligia Araujo Martini. "The role of Vitamin D in obesity and
  146. inflammation at adipose tissue." J Obes Metab Res 2.3 (2015): 161.
  147. - Ching S, Kashinkunti S, Niehaus MD, Zinser GM. Mammary adipocytes bioactivate 25
  148. hydroxyvitamin D3 and signal via Vitamin D3 receptor, modulating mammary epithelial cell growth. J
  149. Cell Biochem 2011;112:3393 405
  150. -Park JE, Pichiah PBT, Cha YS. Vitamin D and Metabolic Diseases: Growing Roles of Vitamin D. J
  151. Obes Metab Syndr. 2018 Dec;27(4):223-232. doi: 10.7570/jomes.2018.27.4.223. Epub 2018 Dec 30.
  152. PMID: 31089567; PMCID: PMC6513299.
  153. -Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease.
  154. JRSM Cardiovasc Dis. 2016;5:2048004016633371. doi:10.1177/2048004016633371.
  155. - Soskić, Sanja, Edita Stokić, and Esma R. Isenović. "The relationship between vitamin D and
  156. obesity." Current medical research and opinion 30.6 (2014): 1197-1199.
  157. -Ouellet, V., Labbe´ , S.M., Blondin, D.P., Phoenix, S., Gue´ rin, B., Haman, F., Turcotte, E.E.,
  158. Richard, D., and Carpentier, A.C. (2012). Brown adipose tissue oxidative metabolism contributes to
  159. energy expenditure during acute cold exposure in humans. J. Clin. Invest. 122, 545–552.
  160. - Szymczak-Pajor, I.; Miazek, K.; Selmi, A.; Balcerczyk, A.; Śliwińska, A. The Action of Vitamin D
  161. in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose Tissue-Related
  162. Metabolic Disorders? Int. J. Mol. Sci. 2022, 23, 956
  163. - Chiang, Janet M; Stanczyk, F. Z. (2018). Vitamin D Levels, Body Composition, and Metabolic
  164. Factors in Asian Indians: Results from the Metabolic Syndrome and Atherosclerosis in South Asians
  165. Living in America Pilot Study. (Thesis).
  166. - Ferira, Ashley Jordan. Vitamin D, insulin sensitivity, and cardiometabolic risk in children. Diss.
  167. University of Georgia, 2011.
  168. -Pelczynska M, Grzelak T, Walczak M, Czyzewska K. Hypovitaminosis D and adipose tissue—cause
  169. and effect relationships in obesity. Ann Agric Environ Med. 2016;23(3):403–9. pmid:27660858.
  170. -Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. Br J Nutr.
  171. ;108(11):1915–23. pmid:23046765.
  172. -Wamberg L, Christiansen T, Paulsen SK, Fisker S, Rask P, Rejnmark L, et al. Expression of vitamin
  173. D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss.
  174. Int J Obes (Lond). 2013;37(5):651–7. pmid:22828938.
  175. -Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in
  176. obesity. Am J Clin Nutr. 2000;72(3):690–3. pmid:10966885.
  177. -Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circ Res. 2014;114(2):379–93.
  178. pmid:24436433.
  179. - Moukayed, Meis, and William B. Grant. "Linking the metabolic syndrome and obesity with vitamin D status:
  180. risks and opportunities for improving cardiometabolic health and well-being." Diabetes, Metabolic Syndrome and
  181. Obesity: Targets and Therapy (2019): 1437-1447.
  182. - Zittermann, Armin, et al. "Vitamin D and cardiovascular disease: an updated narrative review." International
  183. journal of molecular sciences 22.6 (2021): 2896.
  184. -Elkhwanky MS, Kummu O, Piltonen TT, et al. Obesity represses CYP2R1, the vitamin D 25-hydroxylase, in
  185. the liver and extrahepatic tissues. JBMR Plus. 2020;4(11):e10397. doi:10.1002/jbm4.10397
  186. -Tobias, Deirdre K., et al. "Association of body weight with response to vitamin D supplementation and
  187. metabolism." JAMA Network Open 6.1 (2023): e2250681-e2250681

Similar Articles

You may also start an advanced similarity search for this article.